Second Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints
Trial achieves positive results in the treatment of persistent atrial [...]
Trial achieves positive results in the treatment of persistent atrial [...]
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today [...]
“The goal of the Precision Study is to ensure that [...]
“This is an exciting new application of a known medication [...]
“RGX-202 is the only next generation gene therapy for Duchenne [...]
Published online March 19 in the journal Nature, the study [...]
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury [...]
The Audiogene trial is designed to evaluate the safety, tolerability [...]
This article gives an overview of the new clinical trial [...]
“Neuropathy is incredibly common among the aging population, regardless of [...]